{"id":9114,"date":"2018-07-13T13:40:20","date_gmt":"2018-07-13T13:40:20","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=9114"},"modified":"2026-07-23T15:39:56","modified_gmt":"2026-07-23T10:09:56","slug":"car-t-the-future-roadmap-of-the-usd-15-billion-opportunity","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/","title":{"rendered":"T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Although cancer therapeutics continue to be one of the most active areas in terms of drug development, there is still a significant unmet need in this domain. Conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. Amidst the current initiatives to develop more targeted anti-cancer therapies, <a href=\"https:\/\/www.rootsanalysis.com\/reports\/novel-t-cell-immunotherapies-market.html\">T cell therapy<\/a> has emerged as a potent and viable therapeutic intervention to eradicate tumour cells, with minimal side effects. It is based on the principle of harnessing the innate potential of the immune system to target and destroy diseased cells. There are certain key characteristics that render CAR-T cells suitable for use as effective therapeutic tools; these include target specificity, adaptability and the capability to retain immunologic memory.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>With 2 approved therapies and over 365 clinical \/ preclinical product candidates, the CAR-T cells therapies pipeline has evolved significantly over the last few years<\/strong><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"456\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Development-Pipeline-Roots.webp\" alt=\"As per Roots Analysis, currently CAR-T therapies pipeline includes over 365 therapies that are marketed or in clinical stage\" class=\"wp-image-18032\" style=\"object-fit:contain;width:800px;height:540px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Development-Pipeline-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Development-Pipeline-Roots-300x204.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>More than 100 industry players are involved in developing <a href=\"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapies\/\">T cell therapy<\/a>; academic institutes continue to make significant contributions to the innovation in this field<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"452\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Industary-Players-Roots.webp\" alt=\"Around 35% of the CAR-T therapies are currently in discovery stage. Additionally, close to 50% of therapies are used for hematological cancer\" class=\"wp-image-18033\" style=\"object-fit:contain;width:800px;height:537px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Industary-Players-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Industary-Players-Roots-300x202.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The discovery of novel, disease-specific targets has opened up new avenues for the development of CAR-T based treatment options for a diverse range of cancer indications<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A number of prominent scientists have emerged as key opinion leaders in this domain, having led \/ presently leading various CAR-T therapy related clinical development efforts<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Over time, multiple generations of CAR constructs based on a variety of scFv fragments using different vector types, have been developed to improve therapeutic efficiency<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The adoption of marketed therapies indicates that this credible promise can be turned into reality by deploying diverse promotional strategies<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The growing optimism is also evident in the opinions expressed by several industry \/ academic stakeholders and on social media<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>With a robust development pipeline and encouraging clinical outcomes, the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/car-t-cell-therapy-market\/269.html\">CAR T cell therapy market<\/a> is anticipated to grow at an annualized rate of over 50% and be worth USD 15 billion by 2030<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"393\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Market-Growth-upto-2030-Roots.webp\" alt=\"The CAR-T therapies market is fragmented across different segments. Further, it is worth mentioning that market is likely to grow at a CAGR of 50%. \" class=\"wp-image-18034\" style=\"object-fit:contain;width:800px;height:467px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Market-Growth-upto-2030-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/CAR-T-Therapies-Market-Growth-upto-2030-Roots-300x175.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">You can also download the&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/car-t-therapies-market-2nd-edition-2019-2030\/request-sample.html\">SAMPLE REPORT<\/a>&nbsp;on CAR T cells therapy by Roots Analysis.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Our Social Media Platform<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Web:&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/\">https:\/\/www.rootsanalysis.com\/<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">LinkedIn:&nbsp;<a href=\"https:\/\/in.linkedin.com\/company\/roots-analysis\">https:\/\/in.linkedin.com\/company\/roots-analysis<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Twitter:&nbsp;<a href=\"https:\/\/twitter.com\/RootsAnalysis.com\">https:\/\/twitter.com\/RootsAnalysis.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Although cancer therapeutics continue to be one of the most active areas in terms of drug development, there is still a significant unmet need in this domain. Conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. Amidst the current initiatives to develop more targeted anti-cancer therapies, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":19180,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[99,101,60,86,58,1],"tags":[161],"class_list":["post-9114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biologics","category-cell-therapies","category-future-perspectives","category-immunotherapy","category-oncology","category-uncategorized","tag-car-t"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Inside CAR-T&#039;s Race Toward a $15 Billion Future<\/title>\n<meta name=\"description\" content=\"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inside CAR-T&#039;s Race Toward a $15 Billion Future\" \/>\n<meta property=\"og:description\" content=\"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-13T13:40:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T10:09:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity\",\"datePublished\":\"2018-07-13T13:40:20+00:00\",\"dateModified\":\"2026-07-23T10:09:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/\"},\"wordCount\":369,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp\",\"keywords\":[\"CAR-T\"],\"articleSection\":[\"Biologics\",\"Cell Therapies\",\"Future Perspectives\",\"Immunotherapy\",\"Oncology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/\",\"name\":\"Inside CAR-T's Race Toward a $15 Billion Future\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp\",\"datePublished\":\"2018-07-13T13:40:20+00:00\",\"dateModified\":\"2026-07-23T10:09:56+00:00\",\"description\":\"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/07\\\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article CAR-T Therapies at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inside CAR-T's Race Toward a $15 Billion Future","description":"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/","og_locale":"en_US","og_type":"article","og_title":"Inside CAR-T's Race Toward a $15 Billion Future","og_description":"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease","og_url":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2018-07-13T13:40:20+00:00","article_modified_time":"2026-07-23T10:09:56+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp","type":"image\/webp"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity","datePublished":"2018-07-13T13:40:20+00:00","dateModified":"2026-07-23T10:09:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/"},"wordCount":369,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp","keywords":["CAR-T"],"articleSection":["Biologics","Cell Therapies","Future Perspectives","Immunotherapy","Oncology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/","url":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/","name":"Inside CAR-T's Race Toward a $15 Billion Future","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp","datePublished":"2018-07-13T13:40:20+00:00","dateModified":"2026-07-23T10:09:56+00:00","description":"According to Roots Analysis, More than 100 industry players are involved in developing T cells therapies for the treatment of various disease","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/07\/RootsAnalysis_FeaturedImage_T-Cell_Therapy.webp","width":150,"height":150,"caption":"This is a feature image for blog article CAR-T Therapies at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/car-t-the-future-roadmap-of-the-usd-15-billion-opportunity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=9114"}],"version-history":[{"count":7,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9114\/revisions"}],"predecessor-version":[{"id":22363,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/9114\/revisions\/22363"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/19180"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=9114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=9114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=9114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}